Spire Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Spire Wealth Management's IDXX Position: Q2 2026 in Review
Spire Wealth Management increased its Idexx Laboratories (IDXX) stake by 37% in Q2 2026, buying an estimated $36.5K and bringing the position to 239 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #915.
Spire Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.98M in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Spire Wealth Management held 239 shares of Idexx Laboratories worth $126K as of Q2 2026.
- Spire Wealth Management bought 65 Idexx Laboratories shares in Q2 2026, an estimated $36.5K.
- Idexx Laboratories made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #915 holding.
- Spire Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 22 quarters since.
- Spire Wealth Management's Idexx Laboratories position peaked at $6.98M in Q4 2023.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.